Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
Cellartis Deposits Cell Lines with U.S. National Stem Cell Bank; All NIH Human Embryonic Stem Cell Registry Lines Now on Deposit at NSCB
The U.S. National Stem Cell Bank has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden.
Penn Researchers Unlock Molecular Origin of Blood Stem Cells
A research team at the University of Pennsylvania School of Medicine, has identified the location and developmental timeline in which a majority of bone marrow stem cells form in the mouse embryo.
University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels
Researchers at the University of Ottawa Heart Institute have successfully grown blood vessels in damaged muscle tissue by injecting a biomaterial developed specifically to attract new cells and support regeneration.
IBM Research Creates Microscope with 100 Million Times Finer Resolution than Current MRI
IBM Research scientists, in collaboration with the Center for Probing the Nanoscale at Stanford University, have demonstrated magnetic resonance imaging with volume resolution 100 million times finer than conventional MRI.
Protein’s Essential Role in Repairing Damaged Cells Revealed
University of Michigan researchers have discovered that a key protein in cells plays a critical role in two processes affecting the development of cancer.
International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease
International Stem Cell Corporation has created layered human tissue from its unique parthenogenetic stem cells and transplanted this tissue into animals in pre-clinical trials to establish a potential new treatment for human retinal diseases.
Pluristem Therapeutics Files an IND Application with the FDA to Initiate a Phase I Clinical Trial Utilizing PLX-PAD for Critical Limb Ischemia
Pluristem Therapeutics Inc. announced recently that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to begin clinical trials with its placental-derived stromal cell product, termed PLX-PAD, for the treatment of critical limb ischemia.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
The Use of Human Mesenchymal Stem Cell-derived Feeder Cells for the Cultivation of Transplantable Epithelial Sheets
This report shows the efficacy of using human bone marrow derived mesenchymal stem cells as a source of feeder cells for the cultivation of transplantable corneal epithelial cell sheets.
Cell Therapy Generates a Favourable Chemokine Gradient for Stem Cell Recruitment into the Infarcted Heart in Rabbits
This study evaluated the effect of cell therapy using bone marrow stromal cells on an SDF-1 gradient in post-infarction rabbits.
Establishment and Characterization of Hepatic Stem-like Cell lines from Normal Adult Rat Liver
To investigate the mechanism of liver regeneration in vitro, the researchers established hepatic stem cell lines named HY1, HY2 and HY3, derived from a healthy liver of adult rat.
Human Embryonic Stem Cells with Maintenance under a Feeder-Free and Recombinant Cytokine-Free Condition
This paper investigated whether human embryonic stem cells could be maintained under a feeder-free condition without using recombinant cytokines if sizes and numbers of embyronic stem cell colonies were kept within an appropriate range.
Wnt3a Deficiency Irreversibly Impairs Hematopoietic Stem Cell Self-renewal and Leads to Defects in Progenitor Cell Differentiation
This paper studied a mouse deficient for a Wnt gene that seemed to play a nonredundant role in hematopoiesis.
A Forum for International Leaders
The STEM CELLS CONGRESSS
Contributing to the Future of Regenerative Medicine
February 25- 27, 2009 | San Francisco, California
– Address the topics central to the theme of regenerative medicine
– Network with prominent researchers, clinicians, businessmen, and regulators at the cutting edge of their respective fields
– Develop strategies to enable the rapidly expanding therapeutic potential of regenerative medicine
Advance registration Discount Expires Friday, January 23!
Register now and save $200! www.TheStemCellsCongress.com
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.